Marinomed has been successfully represented on the market for several years with its existing portfolio of OTC products to treat cold viruses. The products are available on all continents via partnerships with pharmaceutical companies and pharmacy chains. Rights are currently limited in some countries. If you are interested in selling our OTC products, please contact our BD&L department for further information.
The Carragelose® platform is protected by several patent families and the Marinosolv® technology platform has been registered as a patent in all internationally important target markets.
Marinomed maintains a number of successful partnerships with academic and commercial entities. Some examples of Marinomed's current and previous partners and partner products are listed below.
St. Anna Children`s Hospital, Vienna
Vienna General Hospital (AKH)
Plattform Biomodels Austria
University of Vienna
Medical University of Vienna
University of Veterinary Medicine, Vienna, Laboratory for Tropical Veterinary Medicine
Austrian Institute of Technology (AIT), PET Imaging
Sigmapharm Arzneimittel GmbH